Showing results (171-180 of 319) with videos related to

Sort By:
Pageof 32
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 29, 2012
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter studyG Maschmeyer, W J Heinz, B Hertenstein, et al.
Annals of Hematology|October 31, 1998
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative GroupW Kern, C Aul, G Maschmeyer, et al.
Clinical and Experimental Rheumatology|March 31, 2009
Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cellsP Kolar, S Lach, T Gaber, et al.
Haematology and Blood Transfusion|January 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy for acute leukemias at higher age or after relapseT Büchner, W Hiddemann, M Koenigsmann, et al.
Bone Marrow Transplantation|July 1, 1990
Recombinant human GM-CSF following chemotherapy in high-risk AMLT Buechner, W Hiddemann, M Koenigsmann, et al.
Journal of Visualized Experiments : Jove|May 21, 2015
The multi-organ chip--a microfluidic platform for long-term multi-tissue cocultureEva-Maria Materne, Ilka Maschmeyer, Alexandra K Lorenz, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|October 27, 2004
The effect of Ge incorporation on the Brønsted acidity of ZSM-5Leon G A van de Water, Martijn A Zwijnenburg, Willem G Sloof, et al.
Blood|September 1, 1991
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapseT Büchner, W Hiddemann, M Koenigsmann, et al.
Onkologie|February 1, 1989
Age related randomized comparison of sequentially applied high-dose versus intermediate dose cytosine arabinoside in combination with mitoxantrone (S-HAM) in the treatment of relapsed and refractory acute myeloid leukemia: study design and preliminary resultsW Hiddemann, C Aul, G Maschmeyer, et al.
Annals of Hematology|September 19, 2003
Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Hartmut Bertz, Holger W Auner, Florian Weissinger, et al.
Pageof 32